FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306754737> ?p ?o ?g. }

• W4306754737 abstract "Virgin coconut oil is mostly made up of saturated fatty acids in which approximately 72% are medium chain triglycerides. Medium chain triglycerides can be digested into medium chain fatty acids and medium chain monoglycerides which are bioactive components. Therefore, it is very important to study the in-silico ability of some Virgin coconut oil derivatives, namely, medium chain fatty acids and medium chain monoglycerides to inhibit Cyclooxygenase 2 (COX-2) protein for prevention of excessive inflammatory response.Pharmacophore study displayed monolaurin with two hydrogen bond donor, three hydrogen bond acceptor and five hydrophobic interactions, while lauric acid presented two hydrogen bond acceptor, five hydrophobic interactions and a negative ion interaction. Molecular docking underlined the ability of monolaurin in the inhibition of COX-2 protein which causes inflammatory action with a decent result of energy binding affinity of - 7.58 kcal/mol and 15 interactions out of which 3 are strong hydrogen bond with TYR385 (3.00 Å), PHE529 (2.77 Å), and GLY533 (3.10 Å) residues of the protein. Monolaurin was employed as hydrogen bond acceptor to the side of residue TYR385 of COX-2 protein with an occupancy of 67.03% and was observed to be long-living during the entire 1000 frames of the molecular dynamic simulation. The analysis of RMSD score of the Monolaurin-COX-2 complex backbone was calculated to be low (1.137 ± 0.153 Å) and was in a stable range of 0.480 to 1.520 Å. Redocking of this complex still maintained a strong hydrogen bond (2.87 Å) with the main residue TYR385. AMDET results where promising for medium chain fatty acids and medium chain monoglycerides with good physicochemical drug scores.This can be concluded from the results obtained that the monolaurin has strong interactions with COX-2 protein to disrupt its function due to significant hydrogen bonds and hydrophobic interactions with amino acid residues present in the target protein's active site. These results displayed a very significant anti-inflammatory potential of monolaurin and a new promising drug candidates as anti-inflammatory agent." @default.
• W4306754737 created "2022-10-19" @default.
• W4306754737 creator A5006589288 @default.
• W4306754737 creator A5038251699 @default.
• W4306754737 creator A5078546587 @default.
• W4306754737 date "2022-10-18" @default.
• W4306754737 modified "2023-09-30" @default.
• W4306754737 title "Pharmacophore study, molecular docking and molecular dynamic simulation of virgin coconut oil derivatives as anti-inflammatory agent against COX-2" @default.
• W4306754737 cites W1653739410 @default.
• W4306754737 cites W16685768 @default.
• W4306754737 cites W1968766997 @default.
• W4306754737 cites W1970799005 @default.
• W4306754737 cites W1972148009 @default.
• W4306754737 cites W2014858249 @default.
• W4306754737 cites W2020190711 @default.
• W4306754737 cites W2027393252 @default.
• W4306754737 cites W2030463751 @default.
• W4306754737 cites W2033495141 @default.
• W4306754737 cites W2035581397 @default.
• W4306754737 cites W2042242667 @default.
• W4306754737 cites W2050810064 @default.
• W4306754737 cites W2054870886 @default.
• W4306754737 cites W2077089041 @default.
• W4306754737 cites W2090459068 @default.
• W4306754737 cites W2094235329 @default.
• W4306754737 cites W2098959735 @default.
• W4306754737 cites W2128731431 @default.
• W4306754737 cites W2135732933 @default.
• W4306754737 cites W2213472268 @default.
• W4306754737 cites W2275489002 @default.
• W4306754737 cites W2280071788 @default.
• W4306754737 cites W2321239348 @default.
• W4306754737 cites W2527076982 @default.
• W4306754737 cites W2581896254 @default.
• W4306754737 cites W2607309065 @default.
• W4306754737 cites W2783483586 @default.
• W4306754737 cites W2889030496 @default.
• W4306754737 cites W2896558964 @default.
• W4306754737 cites W2914675673 @default.
• W4306754737 cites W2923209580 @default.
• W4306754737 cites W2969159914 @default.
• W4306754737 cites W2983981549 @default.
• W4306754737 cites W2997462834 @default.
• W4306754737 cites W2998176954 @default.
• W4306754737 cites W3006781192 @default.
• W4306754737 cites W3008142620 @default.
• W4306754737 cites W3009259105 @default.
• W4306754737 cites W3010872301 @default.
• W4306754737 cites W3013223828 @default.
• W4306754737 cites W3016547234 @default.
• W4306754737 cites W3017868152 @default.
• W4306754737 cites W3025110670 @default.
• W4306754737 cites W3036725561 @default.
• W4306754737 cites W3037284688 @default.
• W4306754737 cites W3038428324 @default.
• W4306754737 cites W3094451304 @default.
• W4306754737 cites W3099652235 @default.
• W4306754737 cites W3111580411 @default.
• W4306754737 cites W3122273420 @default.
• W4306754737 cites W3130253446 @default.
• W4306754737 cites W3185108386 @default.
• W4306754737 cites W3205490462 @default.
• W4306754737 cites W4223567516 @default.
• W4306754737 cites W4223579233 @default.
• W4306754737 cites W4229035134 @default.
• W4306754737 doi "https://doi.org/10.1186/s40538-022-00340-0" @default.
• W4306754737 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37520584" @default.
• W4306754737 hasPublicationYear "2022" @default.
• W4306754737 type Work @default.
• W4306754737 citedByCount "3" @default.
• W4306754737 countsByYear W43067547372023 @default.
• W4306754737 crossrefType "journal-article" @default.
• W4306754737 hasAuthorship W4306754737A5006589288 @default.
• W4306754737 hasAuthorship W4306754737A5038251699 @default.
• W4306754737 hasAuthorship W4306754737A5078546587 @default.
• W4306754737 hasBestOaLocation W43067547371 @default.
• W4306754737 hasConcept C112887158 @default.
• W4306754737 hasConcept C121332964 @default.
• W4306754737 hasConcept C159110408 @default.
• W4306754737 hasConcept C178790620 @default.
• W4306754737 hasConcept C185592680 @default.
• W4306754737 hasConcept C204921945 @default.
• W4306754737 hasConcept C26873012 @default.
• W4306754737 hasConcept C2779892579 @default.
• W4306754737 hasConcept C2781003072 @default.
• W4306754737 hasConcept C2781338088 @default.
• W4306754737 hasConcept C32909587 @default.
• W4306754737 hasConcept C41685203 @default.
• W4306754737 hasConcept C521977710 @default.
• W4306754737 hasConcept C543025807 @default.
• W4306754737 hasConcept C56173144 @default.
• W4306754737 hasConcept C71240020 @default.
• W4306754737 hasConcept C71924100 @default.
• W4306754737 hasConcept C90260826 @default.
• W4306754737 hasConceptScore W4306754737C112887158 @default.
• W4306754737 hasConceptScore W4306754737C121332964 @default.
• W4306754737 hasConceptScore W4306754737C159110408 @default.
• W4306754737 hasConceptScore W4306754737C178790620 @default.
• W4306754737 hasConceptScore W4306754737C185592680 @default.
• W4306754737 hasConceptScore W4306754737C204921945 @default.

• next